Latest News about MindMed
Recent news which mentions MindMed
   MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
   
  August 25, 2022
  Tickers 
   MNMD
  
  
  From Benzinga
 
   EXCLUSIVE: Lessons Learned At The Benzinga 2022 Psychedelics And Cannabis Capital Conferences
   
  
  
  April 27, 2022
  From Benzinga
 From Benzinga
 
   MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
   
  December 22, 2021
  Tickers 
   MNMD
  
  
  From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.